The position is immediately available in the Chandra group located in the laboratory of Emeritus Professor Timo Otonkoski within the STEMM Research Program of the Faculty of Medicine.
The project is to investigate the mechanisms of beta cell death in type 1 diabetes using pluripotent stem cells.
Candidates with a PhD, expertise in experimental cell-biology, islet biology, and CRISPR-Cas-mediated genetic editing in stem cells are preferred. Experience in stem cell-derived islet generation, single-cell transcriptomics and bioinformatics is advantageous but not mandatory.
Finland Academic Biology Biotechnology and Genetics On-site Postdoc University of Helsinki